Proposed Rule Would Nix Allowability of Congressional Investigation Costs
Client Alert | 1 min read | 02.17.16
On February 17, the Federal Register published a proposed rule that would amend the FAR to implement section 857 of the National Defense Authorization Act, making unallowable any "costs incurred by a contractor in connection with a Congressional investigation or inquiry into an issue that is the subject a proceeding resulting in a disposition" of criminal convictions, matters involving an allegation of fraud or similar misconduct, suspensions and debarments, and default terminations. The proposed rule would also expand the applicability of section 857's requirements beyond DoD to all agencies subject to the FAR, and, as written, is not clearly limited to the contractor that is actually the subject of the "proceeding or inquiry," an important detail that should be addressed in contractor and industry comments submitted over the next 60 days prior to the publication of the final rule.
Contacts
Insights
Client Alert | 4 min read | 01.07.26
On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026.
Client Alert | 3 min read | 01.07.26
CMMC for AI? Defense Policy Law Imposes AI Security Framework and Requirements on Contractors
Client Alert | 3 min read | 01.07.26
New Year, Same CIPA Uncertainty – When Will the Appellate Courts Enter the Chat?
Client Alert | 11 min read | 01.07.26


